Circulating serum galectin-3 may increase through MMP9-dependent cleavage of membrane-bound galectin-3 [32], and this cleavage of galectin-3 by MMP9 promotes breast cancer angiogenesis and progression [44]. This evidence concerns the gene MMP9 and breast cancer.